{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:29:55Z","timestamp":1762900195532,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.retram.2021.103312","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T02:41:27Z","timestamp":1631846487000},"page":"103312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["HLA and PF4 antibody production after adenoviral vector SARS-CoV-2 vaccination"],"prefix":"10.1016","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4377-0833","authenticated-orcid":false,"given":"Abdellatif","family":"Bouayad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.retram.2021.103312_bib0001","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood.2021012217","article-title":"Frequency of positive anti-PF4\/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2","volume":"138","author":"Thiele","year":"2021","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.retram.2021.103312_bib0002","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.retram.2021.103312_bib0003","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.retram.2021.103312_bib0004","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.retram.2021.103312_bib0005","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1182\/blood-2013-11-540781","article-title":"B-cell tolerance regulates production of antibodies causing heparin-induced thrombocytopenia","volume":"123","author":"Zheng","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.retram.2021.103312_bib0006","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","author":"Huynh","year":"2021","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.retram.2021.103312_bib0007","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/jth.15352","article-title":"An observational study to identify the prevalence of thrombocytopenia and anti-PF4\/polyanion antibodies in Norwegian health care workers after COVID-19 vaccination","volume":"19","author":"S\u00f8rvoll","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"20","key":"10.1016\/j.retram.2021.103312_bib0008","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1182\/bloodadvances.2019000311","article-title":"Association between the HLA-DRB1\u00d703:01-DQB1\u00d702:01 haplotype and PF4\/heparin antibodies","volume":"3","author":"Zhang","year":"2019","journal-title":"Blood Adv"},{"issue":"12","key":"10.1016\/j.retram.2021.103312_bib0009","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/bloodadvances.2021004904","article-title":"A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2","volume":"5","author":"T\u00f8lb\u00f8ll S\u00f8rensen","year":"2021","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.retram.2021.103312_bib0010","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/phar.1983","article-title":"Influence of Human Leukocyte Antigen (HLA) Alleles and Killer Cell Immunoglobulin-Like Receptors (KIR) Types on Heparin-Induced Thrombocytopenia (HIT)","volume":"37","author":"Karnes","year":"2017","journal-title":"Pharmacotherapy"},{"issue":"14","key":"10.1016\/j.retram.2021.103312_bib0011","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1182\/blood-2016-04-709634","article-title":"The antigenic complex in HIT binds to B cells via complement and complement receptor 2 (CD21)","volume":"128","author":"Khandelwal","year":"2016","journal-title":"Blood"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318621000386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318621000386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:40:13Z","timestamp":1762821613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318621000386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2452318621000386"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2021.103312","relation":{},"ISSN":["2452-3186"],"issn-type":[{"type":"print","value":"2452-3186"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA and PF4 antibody production after adenoviral vector SARS-CoV-2 vaccination","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2021.103312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103312"}}